Flanvotumab
Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody targeting tyrosinase-related protein (TYRP1), exhibiting potent antitumor activity through natural killer-mediated and antibody-dependent cell-mediated cytotoxicity (ADCC) .
Product Specifications
CAS Number
1188277-05-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Tyrosinase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6440505-02 5x 0.1 mL
TGM3 (Transglutaminase 3, TGE) (MaxLight 490)
Sign In for Pricing
View Details abx343192-01 20 µL
Histone H2A type 1 / HIST1H2AG (H2AC11) Antibody
Sign In for Pricing
View Details abx343192-02 50 µL
Histone H2A type 1 / HIST1H2AG (H2AC11) Antibody
Sign In for Pricing
View Details abx343192-03 100 µL
Histone H2A type 1 / HIST1H2AG (H2AC11) Antibody
Sign In for Pricing
View Details abx343192-04 200 µL
Histone H2A type 1 / HIST1H2AG (H2AC11) Antibody
Sign In for Pricing
View Details